Status:
COMPLETED
The Efficacy of Hypnotic Cognitive Therapy for Chronic Pain in SCI
Lead Sponsor:
University of Washington
Collaborating Sponsors:
The Craig H. Neilsen Foundation
Conditions:
Spinal Cord Injuries
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic pain is prevalent and disabling in people with spinal cord injury (SCI). Medications alone often do not cure the pain. Pilot research suggests that training in the combination of self-hypnosis...
Detailed Description
This is a two-group randomized controlled trial designed to determine whether videoconferencing-delivered, hypnosis enhanced cognitive therapy (HYPNOCT) is an effective treatment for chronic SCI-relat...
Eligibility Criteria
Inclusion
- Adults aged 18 years or older;
- diagnosis of SCI at any level or severity;
- completed inpatient rehabilitation (to ensure diagnosis and sufficient severity of SCI);
- of ≥ 4 on a 0-10 NRS of pain intensity in the last week (during both the screening and baseline examinations)
- reports that pain interferes with general activities (rates pain interference ≥ 1 on 0-10 scale)
- reports pain has been present 12 weeks or more (chronic);
- reports being able to read and speak English.
- Have access to a webcam \& microphone through either a computer, smartphone, or other internet-connected device.
Exclusion
- Severe cognitive impairment defined as one or more errors on the Six-Item Screener;
- presence or history of mental health problems that would require referral for more intensive treatment or complicate hypnotic treatment (current suicidal ideation with intent or plan to harm oneself, current drug or alcohol dependence, lifetime history of bipolar disorder, psychosis, paranoid disorder based on screening questions from the M.I.N.I Neuropsychiatric Interview;
- primary chronic pain problem pre-dated SCI (e.g., chronic headache);
- has not undergone a previous medical evaluation for their pain to rule out treatable causes or undiagnosed disease (e.g., cancer);
- unstable pain medication regimen (dosage changes within the past 3 weeks);
- currently receiving CT or hypnosis for pain or has failed prior treatment with CT or hypnosis; and
- declines to provide informed consent.
Key Trial Info
Start Date :
April 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT03857672
Start Date
April 24 2019
End Date
March 31 2022
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehabilitation Medicine, Harborview Medical Center
Seattle, Washington, United States, 98195